GRMLWNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Market cap
$1.054 M
$0.18 +20.07%
Close of 21 Sept 2026
Revenue
—
Not reported
Earnings
-$10.6M
Loss-making
Shares outstanding
121,238,660
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Other share classes
Greenland Mines lists more than one class of stock. Company figures above cover all classes combined.
Insiders buying
All insider buying →One open-market purchase by officers and directors of Greenland Mines, worth $136.1K. Grants and option exercises are excluded.
14,000 shares at $9.72 on 25 Aug 2026 · filed 25 Aug 2026
Where these numbers come from
Share counts and financials for Greenland Mines are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.